Pggm Investments’s Regeneron Pharmaceuticals Position
Does Pggm Investments own Regeneron Pharmaceuticals (REGN)? Yes — 92.6K shares worth $72M (+1.25% of its 13F portfolio) as of Q1 2026.
Position Value
$72M
Q1 2026
Shares
92.6K
% of Portfolio
+1.25%
Quarters Held
19
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 92.6K | $72M | +1.25% |
| Q4 2025 | 92.6K | $71M | +1.13% |
| Q3 2025 | 92.6K | $52M | +0.84% |
| Q2 2025 | 84.4K | $44M | +0.77% |
| Q1 2025 | 32.5K | $21M | +0.28% |
| Q4 2024 | 32.5K | $23M | +0.31% |
| Q3 2024 | 26.2K | $28M | +0.35% |
| Q2 2024 | 32.7K | $34M | +0.49% |
| Q1 2024 | 36.0K | $35M | +0.50% |
| Q4 2023 | 36.0K | $32M | +0.48% |
| Q3 2023 | 56.6K | $47M | +0.80% |
| Q2 2023 | 54.6K | $39M | +0.64% |
| Q1 2023 | 50.2K | $41M | +0.69% |
| Q4 2022 | 47.8K | $34M | +0.60% |
| Q3 2022 | 44.7K | $31M | +0.54% |
| Q1 2022 | 8.8K | $6M | +0.03% |
| Q4 2021 | 8.8K | $6M | +0.03% |
| Q3 2020 | 69.4K | $39M | +0.20% |
| Q2 2020 | 48.0K | $30M | +0.17% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pggm Investments’s full portfolio or all institutional holders of REGN.